An Analysis of the Improvement and Quality of Life Trends for UK/ROI Patients Treated With Cosentyx (Secukinumab) in a Retrospective Analysis of the BADBIR Data Source
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
A Study of Sabatolimab and Magrolimab-based Treatment in AML or Higher Risk MDS Participants
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL)
- Status
- COMPLETED
- Phase
- N/A
A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting
- Status
- COMPLETED
- Phase
- N/A
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI)
- Status
- COMPLETED
- Phase
- N/A
Evaluation of the Effectiveness of Secukinumab in Patients With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- N/A
A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
- Status
- RECRUITING
- Phase
- N/A
Long-term Follow-up of Patients With Spinal Muscular Atrophy Treated With OAV101 in Clinical Trials
- Status
- RECRUITING
- Phase
- PHASE3
Study of Crizanlizumab for Prevention of Silent Cerebral Infarcts in SCA
- Status
- UNKNOWN
- Phase
- NA
A Survey to Evaluate Early Experience From Patient and Care Partner on Injection and Device for KESIMPTA® Indicated for Multiple Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Study to Compare the Pharmacokinetics, Safety and Tolerability of the Pediatric and Adult Branaplam Formulation in Healthy Adults and the Effect of Food on the Latter.
- Status
- TERMINATED
- Phase
- PHASE1
Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Efavirenz
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study to Evaluate the Pharmacokinetics of JDQ443 in Participants With Hepatic Impairment Compared to Matched Healthy Control Participants.
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Tolerability Study of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF)
- Status
- COMPLETED
- Phase
- PHASE1
Treatment Effectiveness Among Psoriasis Patients Treated With Cosentyx (Secukinumab)
- Status
- COMPLETED
- Phase
- N/A
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Rate of Weekly Lipoprotein Apheresis Sessions in Patients With Hyperlipoproteinemia(a) and Established Cardiovascular Disease in Germany
- Status
- COMPLETED
- Phase
- PHASE3